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Tibetan precious pills are an integral part of TTM (Traditional Tibetan Medicine). Among them, Rinchen
Drangjor Rilnag Chenmo (RDRC) has been named “King of Precious Pills” due to its efficacy in treating a
multitude of human disorders. RDRC has a complex formulation with about 140 ingredients, mostly
from medicinal plants and a few precious stones and metals. Not many studies have been done on the
experimental  validation  of  antimicrobial  properties  of  this  important  pill.  The  current  study
investigated the antimicrobial activity of the extracts of RDRC. Both aqueous and chloroform extracts
were evaluated for their  antibacterial  potential against a total  of seven different bacterial  species,
which are pathogenic, including three species of  Vibrio,  viz. V. vulnificus,  V. parahaemolyticus and V.
harveyi  using the well-diffusion method and also by assessing MIC and MBC values.  Its  antifungal
potential was also studied against two fungal strains  Aspergillus niger  and Talaromyces islandicus. It
was found that the chloroform extract of RDRC exerted a positive antibacterial effect on all the Vibrio
species tested, and the least MIC of 3.33 mg/ml was observed for V. parahaemolyticus. This is the first
study of its kind on the anti-Vibrio effect of the Tibetan precious pill, Rinchen Drangjor Rilnag Chenmo.
Introduction
Traditional  Tibetan  Medicine  (TTM),  also  known  as
Sowa-Rigpa in Tibetan (literally translates to “Science
of  Healing'')  is  one of  the  oldest  traditional  medical
systems dating back to the 4th century (1) and world’s
first  integrative medicine (2) with its influence from
Chinese,  Greco-Arab,  Himalayan and Indian medical
systems in the 8th century (3). Since then, this holistic
and comprehensive medical system has developed as
the main medical system in Tibet. Currently, TTM has
gained  its  popularity  in  India,  Nepal,  Bhutan,
Mongolia, China and western countries. In September
2010,  Indian  Government  officially  recognized  the
Sowa-Rigpa  as  an  integral  part  of  its  national
healthcare system, making it the fourth country after
China, Bhutan and Mongolia to recognize it (4). One of
the  most  important  precious  pills  in  Traditional
Tibetan Medicine is Rinchen Drangjor Rilnag Chenmo
(RDRC).  It  is  considered the  “King  of  Precious  Pills''
among  the  eight  precious  pills  (6).  It  has  been
proposed to cure a multitude of diseases and also has
rejuvenating effects  on the healthy.  It  is  believed to
enhance complexion and clear sense organs. It is also
a  rejuvenator,  acts  as  an  aphrodisiac,  strengthens
nerves,  blood  vessels  and  bones  (6).  RDRC  is
considered to  have  prophylactic  effects  too  (6).  It  is
given for a range of diseases from simple to complex
and diseases caused by environmental pollution (5). It
is  also  used  as  a  tonic  and  worn  as  a  protective
amulet. RDRC is found to have about 140 ingredients,
including  detoxified  Mercury  or  Tsothel.  It  also
contains  powder  from  precious  stones  and  metals
such as gold, silver, copper, iron, sapphire, diamond,
emerald,  turquoise  etc  (6).  Some  of  the  important
medicinal plants used to prepare these pills are Crocus
sativus  Linn.,  Myristica  fragrans  Houtt.,  Phytolacca
esculenta  van Houtte., Terminalia bellerica  Roxb. and
Terminalia chebula  Retz. (6). The preparation method
of RDRC has been done sacredly by only a few Tibetan
masters  and is  created  on the basis  of  the  practical
instructions  of  the  great  ancient  Masters  of  Tibetan
medicine and enriched with their spiritual  blessings.
RDRC  has  been  predicted  to  cure  diseases  of  the
gastrointestinal  tract,  infectious  fevers,  colic  in  the
small intestine and even cancer (6).  It has also been
found  to  eliminate  grey  hair,  wrinkles  and  is  also
known to strengthen bones. In China, RDRC has made
it to the UNESCO inspired ‘Intangible cultural heritage
list’ in 2006 (7, 8).  Since its recognition in India from
2010, no work has been done to scientifically validate
its claim that is to treat infectious diseases, there is not
one single scientific  paper on this pill  to back up its
claim. Therefore, we  decided  to  test  the  efficacy  of
both  the  chloroform  and  aqueous  extracts  of  RDRC
© Dhargyal et al (2021). This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, 
distribution and reproduction in any medium, provided the original author and source are credited (https://creativecommons.org/licenses/by/4.0/).






against  two  Gram-positive  and  five  Gram-negative
bacteria and two fungal species.
Materials and Methods
Sample collection
Rinchen Drangjor Rilnag Chenmo (RDRC) pills  were
bought  from  the  Men-Tsee-Khang  branch  clinic  in
Koramangala,  Bangalore,  after  permission from the
Director  of  Men-Tsee-Khang  (Tibetan  Medical  and
Astro-science Institute), Himachal Pradesh, India.
Microbial strains
Staphylococcus  aureus  (ATCC  29213)  and  Bacillus
velezensis (MW219533.1)  were used as the bacterial
indicator  strains  for  Gram-positive  bacteria.
Escherichia coli  (ATCC  MG1655),  Pseudomonas
aeruginosa  (ATCC  27853),  Vibrio  harveyi,  Vibrio
parahaemolyticus and Vibrio vulnificus  were used as
the  bacterial  indicator  strains  for  Gram-negative
bacteria  for  antibacterial  studies.  Aspergillus  niger
(MT123512.1)  and  Talaromyces  islandicus
(MT123786.1)  were  used  for  checking  antifungal
activity. Some cultures have been maintained in the
University and few were a gift from IISc, Department
of Cell and Molecular Biology. The culture collection
details are given in brackets.
Extraction process
10  gm  of  pulverized  pills  were  packed  uniformly
inside a thimble,  and a sample was extracted using
120 ml chloroform in a distillation flask at the boiling
point  of  chloroform  (62  °C).  During  the  process,
condensated  fresh  chloroform  gradually  fills  the
thimble  holder,  and  once  it  reaches  the  overflow
level,  the solute  is  aspirated by siphoning from the
thimble  holder  back  to  the  distillation  flask  with
extracted analytes (9). This process was repeated for
7 hrs until the extractant became colourless. Because
of  the  large  amount  of  solvent  used,  the
concentration  step  was  essential  after  extraction
using  Rotary  evaporator  (Royal  Scientific  137).  The
same RDRC sample was dried in a hot air oven and
sequentially extracted using distilled water for 18 hrs
and concentrated using rotavapor. The dried extracts
were stored at 4  for further uses.℃
Phytochemical analysis
The RDRC extracts were subjected for phytochemical
analysis  by  employing  standard  methods  such  as
alkaline  reagent  test  for  flavonoids,  Benedict’s
reagent test for carbohydrates, ferric chloride test for
phenols,  steroids,  tannins,  foam  test  for  saponins,
Mayer’s  test  for  alkaloids  and  Salkowski’s  test  for
glycosides (10).
Antibacterial assay
The aqueous and chloroform extracts of RDRC were
checked for  their  antibacterial  activity  using the  in
vitro  agar  well-diffusion method (11).  Sterile  cotton
swabs were used to inoculate the cultured microbial
strains  on  Mueller-Hinton  (MH)  agar  (HiMedia
Laboratories Pvt. Ltd.) plates for antibacterial study.
A sterile well-borer of 5.0 mm diameter was used to
make wells, and different concentrations of aqueous
and chloroform extracts were loaded (0.25, 0.50, 0.75,
1.0, 1.25 and 1.5 mg/ml). 10 mg/ml of aqueous extract
was prepared in  sterile  distilled  water,  whereas  10
mg/ml  of  chloroform  extract  was  prepared  in
Dimethyl Sulfoxide (Qualikems Fine Chem Pvt. Ltd.).
Ampicillin (HiMedia Laboratories Pvt. Ltd.) was used
as a positive control for an antibacterial study. Since
the  chloroform  extract  was  dissolved  in  Dimethyl
Sulfoxide  (DMSO),  DMSO was treated  as  a  negative
control.  The bacterial  plates  were incubated  for  24
hrs  at  37  ºC.  Its  antibacterial  activities  were
measured  using  a  zone  of  inhibition  (ZOI)  in
millimetre  (mm).  It  was  done  in  triplicates  under
aseptic conditions.
Determination of MIC and MBC
Minimum  Inhibitory  Concentration  (MIC)  of  RDRC
extract was assessed by tube dilution method. Serial
two-fold dilutions of the extract were made starting
from  20  mg/ml  Mueller-Hinton  Broth  to  assess
bacterial  growth.  The  concentrations  used  for  the
MIC  study  included  20,  10,  5,  2.5,  1.25,  0.625  and
0.3125  mg/ml.  Overnight  cultures  of  bacteria  were
inoculated in MH broth with different RDRC extract
concentrations,  incubated  at  37  °C  overnight  in  a
shaker  incubator  (Orbital  Shaker  Incubator  (Remi
CIS-24BL), and turbidity measurements (Colorimeter,
ELICO, CL137) were taken the next day at OD600. MIC
was  determined  as  the  lowest  concentration  that
inhibited  the  visible  growth  of  microorganisms.  In
order  to  assess  the  Minimum  Bactericidal
Concentration  (MBC),  aliquots  of  50 μl  from all  the
tubes which showed no visible bacterial growth were
seeded on MH agar plates and incubated for 24 hr at
37 °C. The number of colonies counted the next day.
When 99.9% of the bacterial  population is killed at
the least concentration of an antimicrobial agent, it is
fixed as its MBC. This was done by observing pre- and
post-incubated  agar  plates  for  the  presence  or
absence  of  bacterial  colonies.  Experiments  were
replicated thrice (n=3) and represented as mean ± SD.
Anti fungal assay
Sterile  cotton  swabs  were  used  to  inoculate  the
cultured  fungal  strains  on  Potato  Dextrose  Agar
(HiMedia Laboratories Pvt. Ltd.) plates for antifungal
study.  A  sterile  well-borer  of  5  mm  diameter  was
used to make wells, and different concentrations of
aqueous and chloroform extracts were loaded (0.25,
0.50,  0.75,  1.0,  1.25  and  1.5  mg/ml).  10  mg/ml  of
aqueous  extract  was  prepared  in  sterile  distilled
water, whereas 10 mg/ml of chloroform extract was
prepared  in  DMSO.  Sporanox  (Johnson  &  Johnson
Pvt. Ltd.) was used as a positive control for antifungal
study (12). DMSO was used as a negative control. The
fungal plates were kept at room temperature for 5–7
days.  Its  antifungal  activities  were  assessed  by
measuring the zone of inhibition (ZOI) in millimetre
(mm).  It  was  also  done in  triplicates  under  aseptic
conditions. 
Statistical analysis
All the values were expressed as mean ± S.D of three
parallel  measurements.  Statistical  analyses  for  the
antimicrobial  activities  were  performed  using  the
SPSS  software  package.  The  mean  values  were
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analyzed  by  one-way  ANOVA.  To  determine  the
statistical  significance  of  antimicrobial  activity,
Duncan’s  Multiple  Range Test  (DMRT)  was used.  p-
values < 0.05 were regarded as significant.
Results and Discussion
Natural  medicines  derived  from  parts  of  plants,
animals and minerals obtained from Earth have been
found  to  play  important  roles  in  fighting  various
diseases.  With  its  long  history  of  more  than  2000
years, Traditional Tibetan  Medicine (TTM) has been
well recognized in Tibet and other parts of the world.
TTM has been considered to play a significant role in
the  prevention  and  treatment  of  various  diseases,
including cancer (5). In the current study, the extract
of the pill RDRC was prepared using chloroform and
water. Water was used for extraction of the polar and
semi-polar  constituents.  However,  for  lipophilic
compounds,  lipophilic  solvents  such  as  chloroform
were used for extraction. The phytochemical analysis
of  both  extracts  as  shown in  Table  1  indicated  the
presence  of  alkaloids,  carbohydrates,  flavonoids,
glycosides,  phenols,  saponins,  steroids  and tannins.
These  RDRC  extracts  were  screened  in  vitro for
antibacterial  activity  by  the  agar  well  diffusion
method  (Table  2  and  3).  Both  the  extracts  did  not
show  any  activity  against  tested  Gram-positive
bacteria,  as shown in Table 3. However, chloroform
extract exhibited considerable activity (Fig. 1) against
three Vibrio species: V. harveyi at 1, 1.25 and 1.5 mg/
ml showed zone of inhibition (ZOI) of 7.0 ± 0.0, 9.0 ±
1.0 and 10.0 ± 0.0 mm respectively;  V. vulnificus at
0.75, 1, 1.25 and 1.5 mg/ml exhibited ZOI of 5.6 ± 0.5,
7.6  ±  0.5,  9.3  ±  0.5  and  10  ±  1.0  mm;  V.
parahaemolyticus  was  more  sensitive  with  its  ZOI
noticeable even at 0.25 mg/ml as displayed in Table 2.
Since  the  chloroform  extract  was  dissolved  using
DMSO  and  diluted  using  distilled  water,  DMSO
(Solvent)  inhibition  was  also  checked,  and  it
exhibited no inhibition. RDRC extracts were assayed
for antifungal activity against two fungal strains, but
both  the  extracts  were  inactive  and  exhibited  no
fungicidal activities (Table 4).
MIC  values  were  assessed  for  the  three  Vibrio
species for which RDRC extract showed antibacterial
activity as evidenced by the zone of inhibition.  The
least MIC value (3.33 ± 1.44 mg/ml) was observed for
V. parahaemolyticus and the highest (5.00 ± 0 mg/ml)
for  V.  harveyi.  MBC  values  were  calculated  for  V.
parahaemolyticus,  V. vulnificus  and V. harveyi  (Table
5), in which V. parahaemolyticus had the least MBC of
8.33 ± 2.88 mg/ml, which shows that the chloroform
extract of RDRC was the most efficacious against  V.
parahaemolyticus.
Many  Vibrio species have been associated with
aquatic ecosystems. V, parahaemolyticus is commonly
found in rivers and estuaries. Food poisoning caused
by V. parahaemolyticus usually occurs in summer. It
is  mostly  manifested  in  people  consuming  seafood
like crab, shrimp, shellfish, lobster, fish and oysters
(13–14).  V.  parahaemolyticus is  a  human  pathogen
and  can  cause  acute  gastroenteritis  due  to
contaminated  raw  or  undercooked  seafood.  It  also
can  cause  infections  in  open  wounds  exposed  to
seawater.  This  Gram-negative  comma-shaped
bacterium  is  the  leading  cause  of  seafood-related
gastroenteritis  (15).  V. parahaemolyticus  is  reported
to  cause around  35000  cases  of  gastroenteritis  per
year  in  the  USA  alone  (16).  Certain  serogroups  of
bacteria causing various gastroenteritis diseases turn
out  to  be  highly  virulent  and  can  even  cause
pandemics.  One  such  is  the  O3:K6  serogroup  of  V.
parahaemolyticus, which  emerged  in  India  in  1996
and has since spread to other Asian countries (17).
Some strains of  V. parahaemolyticus have been
found  to  be  antibiotic-resistant.  Hence,  the  use  of
synthetic antibiotics should be done with caution as
these  inhibitors  based on chemical  molecules  often
lead to bacterial drug resistance or leave residues in
the environment, which can pose a threat to animal
and  human  health  (18).  In  this  scenario,  the
importance of natural products to combat pathogens
can be looked at. Most of the ingredients of RDRC are
obtained  from  nature.  The  current  study  showed
significant  anti-Vibrio  activity  against  V.
parahaemolyticus as  evidenced  by  the  zone  of
inhibition of about 13 mm. In another study, natural
products  like  cumin  have  been  reported  to  have
antibacterial effects on V. parahaemolyticus (19).
Vibrio  vulnificus causes  both  foodborne  and
wound  infections  and  is  notorious  for  being
responsible for the highest death rate caused by any
foodborne  disease  agent  in  the  USA  (20).  This
pathogen is highly invasive and can cause septicemia
in  persons  with  reduced  immunity;  and  is
responsible for 95% of all  seafood-related deaths in
the USA, with a mortality rate of 60% (21). But not all
strains of  V. vulnificus have been found to be highly
virulent (22). Most of the deaths occur within 72 hrs if
proper  treatment  is  not  given.  Generally,  a
combination  of  tetracyclines  and  third-generation
cephalosporins  are  given  as  treatment.  There  has
been increasing  evidence  of  V.  vulnificus becoming
resistant  to  antibiotics  and  hence,  it  becomes
necessary to explore newer anti-Vibrio  compounds,
especially  of  natural  origin.  A  previous  report  has
depicted the anti-Vibrio activity of the plant  Ocimum
gratissimum  Linn.  (23).  Present study has yielded a
positive  result  for  antibacterial  activity  of  RDRC
extract against V. vulnificus, as the zone of inhibition
was found to be about 10 mm. Hence, this  Tibetan
Precious pill, RDRC can be thought of as a part of the
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(+) represents the presence of the mentioned compounds and (-) 
represents the absence of the compounds.
anti-Vibrio therapy for manifestations of V. vulnificus
infections which are life-threatening.
The  third  bacterium  we  tested  using  RDRC
extract was  V. harveyi.  It is facultatively  anaerobic,
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Table 2. Antibacterial activity of RDRC extracts in comparison with standard antibiotic ampicillin against Gram-negative bacterial strains
Compound Conc. (mg/ml)








0.25 0 0 0 0 0.6 ± 0.0
0.50 0 0 0 0 0.7 ± 0.0
0.75 0 0 5.6 ± 0.5 0 10.0 ± 1.0
1.00 0 0 7.6 ± 0.5 7.0 ± 0.0 11.3 ± 0.5
1.25 0 0 9.3 ± 0.5 9.0 ± 1.0 12.00 ± 0
1.50 0 0 10 ± 1.0 10.0 ± 0.0 13 ± 2.00
Aqueous 
extract
0.25 0 0 0 0 0
0.50 0 0 0 0 0
0.75 0 0 0 0 0
1.00 0 0 0 0 0
1.25 0 0 0 0 0
1.50 0 0 0 0 0
Ampicillin 0.5 0 14 ± 1.0 17.6 ± 0.5 19 ± 0.0 20 ± 2.0
DMSO 0 0 0 0 0
values are presented as mean ± standard deviation of three independent experiments where p < 0.05
Table 3. Antibacterial activity of RDRC extracts in comparison with standard antibiotic ampicillin against Gram-positive bacterial strains
Compound Conc. (mg/ml)
Zone of Inhibition (mm)















Ampicillin 0.50 27.6 ± 2.5 12.6 ± 2.0
DMSO 0 0
values are presented as mean ± standard deviation of three independent experiments (p < 0.05)
Table 4. Antifungal activity of RDRC extracts in comparison with standard antifungal sporanox against fungal strains
Compound Conc. (mg/ml)
Zone of Inhibition (mm)















Sporanox (Itraconazole) 0.50 18.0 ± 1.0 7.6 ± 0.5
DMSO 0 0 0
values are presented as mean ± standard deviation of three independent experiments (p < 0.05).
Table 5. MIC and MBC of chloroform extract of RDRC against Vibrio species
 Bacterial species MIC (mg/ml) MBC (mg/ml)
Vibrio vulnificus 4.16 ± 1.44 10.0 ± 0.00
Vibrio harveyi 5.0 ± 0.00 13.33 ± 5.77
Vibrio parahaemolyticus 3.33 ± 1.44 8.33 ± 2.88
values are presented as mean ± standard deviation of three independent experiments (p < 0.05).
halophilic,  bioluminescent  and motile  (24).  As  with
other  Vibrio  species,  V.  harveyi is  also  found  in
tropical marine waters and also lives as a commensal
in the gut microflora of marine animals.  V. harveyi




Fig. 1. Well diffusion method to check the antibacterial activity of Rinchen Drangjor Rilnag Chenmo (RDRC) chloroform 
extract at concentrations of 0.25, 0.5, 0.75, 1, 1.25 and 1.5 mg/ml against Vibrio parahaemolyticus (A) Vibrio vulnificus (B) and 
Vibrio harveyi (C) depicting zones of inhibition. Ampicillin was used as the standard antibiotic.
has  been  found  to  cause  mass  mortality  events  in
benthic invertebrates in the Mediterranean Sea. This
pathogen has also been pinpointed as a major threat
to  the  survival  of  marine  animals  due  to  disease
outbreaks owing to dramatic  climate change events
(25).  The  first  report  giving  evidence  of  V.  harveyi
being a human pathogen was published in 1989, of an
11 year old girl bitten by a shark in California and
subsequently  getting  wound  infection  in  the  year
1985  (26).  The  organism  was  confirmed  to  be  V.
harveyi by  the  Centre  for  Disease  Control,  CDC.
Another  four  more  cases  were  reported  later,
pointing to the fact that  V. harveyi can cause human
infections,  though the chances are rare. There have
been previous reports of Silver nanoparticles of tea
leaf  extract  (27)  and  colloidal  Silver  nanoparticles
(28) offering antibacterial activity against  V. harveyi.
Present  study  also  has  revealed  potential
antibacterial  activity  against  V.  harveyi by  the
chloroform extract of RDRC.
The anti-Vibrio effects of RDRC could be due to
the  combined  mode  of  action  of  different  plant
extracts present in the pill. Methyl gallate, one of the
active  ingredients  of  T.  chebula  Retz.,  a  major
component  of  RDRC  has  been  found  to  act  as  an
effective agent for the treatment of severe secretory
and  inflammatory  diarrheal  diseases  caused  by
multidrug-resistant strains of V. cholerae (29). A high
level  of  antibacterial  activity  was  reported  for  V.
parahaemolyticus by the use of extracts of Phytolacca
americana Linn. (30). Myrtiscin and Eugenol found in
Myristica  fragrans Houtt.,  another  predominant
constituent  of  RDRC,  have  been  shown  to  have
excellent antibacterial action against V. cholerae (31).
Our  preliminary  antibacterial  studies  for  the  three
highly  pathogenic  Vibrio species  have  depicted  the
potential  antagonistic  action  of  the  extract  of  the
Tibetan  precious  pill  RDRC  against  these  bacteria
causing life-threatening infections. 
Conclusion
The  current  study  was  successful  in  validating  the
antibacterial  effect of the chloroform extract of the
Tibetan  Precious  Pill,  Rinchen  Drangjor  Rilnag
Chenmo (RDRC),  against three highly infectious and
virulent  Vibrio species.  Further  studies  are  being
planned to investigate  the molecular  mechanism of
disruption of bacterial growth. This will definitely be
useful in proving the projected success of such pills in
treating  a  multitude  of  diseases  ailing  humankind.
Globally, different ethnic groups have evolved their
own  traditional  medical  practices,  some  of  which
have  really  been  shown  to  be  efficient  in  curing
dreaded  diseases.  With  the  advancements  made  in
biochemistry and molecular biology, more scientific
validation of the medicinal effects of such traditional
pills is indeed the need of the hour.
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